Voraratt Champattanachai, Ph.D. - Publications

Affiliations: 
2008 University of Alabama, Birmingham, Birmingham, AL, United States 
Area:
Cell Biology

17 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Verathamjamras C, Sriwitool TE, Netsirisawan P, Chaiyawat P, Chokchaichamnankit D, Prasongsook N, Srisomsap C, Svasti J, Champattanachai V. Aberrant RL2 O-GlcNAc antibody reactivity against serum-IgA1 of patients with colorectal cancer. Glycoconjugate Journal. 38: 55-65. PMID 33608772 DOI: 10.1007/s10719-021-09978-8  0.398
2020 Netsirisawan P, Chokchaichamnankit D, Saharat K, Srisomsap C, Svasti J, Champattanachai V. Quantitative proteomic analysis of the association between decreasing O‑GlcNAcylation and metastasis in MCF‑7 breast cancer cells. International Journal of Oncology. PMID 32236627 DOI: 10.3892/Ijo.2020.5022  0.319
2019 Weeraphan C, Phongdara A, Chaiyawat P, Diskul-Na-Ayudthaya P, Chokchaichamnankit D, Verathamjamras C, Netsirisawan P, Yingchutrakul Y, Roytrakul S, Champattanachai V, Svasti J, Srisomsap C. Phosphoproteome profiling of isogenic cancer cell-derived exosome reveals HSP90 as a potential marker for human cholangiocarcinoma. Proteomics. e1800159. PMID 31054213 DOI: 10.1002/Pmic.201800159  0.324
2018 Netsirisawan P, Chaiyawat P, Chokchaichamnankit D, Lirdprapamongkol K, Srisomsap C, Svasti J, Champattanachai V. Decreasing O-GlcNAcylation affects the malignant transformation of MCF-7 cells via Hsp27 expression and its O-GlcNAc modification. Oncology Reports. 40: 2193-2205. PMID 30106436 DOI: 10.3892/Or.2018.6617  0.522
2017 Ngiwsara L, Rojnueangnit K, Wattanasirichaigoon D, Tim-Aroon T, Sawangareetrakul P, Champattanachai V, Ketudat-Cairns JR, Svasti J. Molecular analysis of the novel IDS allele in a Thai family with mucopolysaccharidosis type II: The c.928C>T (p.Gln310*) transcript is sensitive to nonsense-mediated mRNA decay. Experimental and Therapeutic Medicine. 13: 2989-2996. PMID 28588666 DOI: 10.3892/Etm.2017.4303  0.33
2016 Chaiyawat P, Weeraphan C, Netsirisawan P, Chokchaichamnankit D, Srisomsap C, Svasti J, Champattanachai V. Elevated O-GlcNAcylation of Extracellular Vesicle Proteins Derived from Metastatic Colorectal Cancer Cells. Cancer Genomics & Proteomics. 13: 387-398. PMID 27566657  0.404
2015 Sawangareetrakul P, Ketudat Cairns JR, Vatanavicharn N, Liammongkolkul S, Wasant P, Svasti J, Champattanachai V. Analysis of Novel Mutations and Methylmalonyl-CoA Mutase Levels in Thai Patients with Isolated Methylmalonic Acidemia. Biochemical Genetics. 53: 310-8. PMID 26370686 DOI: 10.1007/S10528-015-9694-9  0.309
2015 Chaiyawat P, Chokchaichamnankit D, Lirdprapamongkol K, Srisomsap C, Svasti J, Champattanachai V. Alteration of O-GlcNAcylation affects serine phosphorylation and regulates gene expression and activity of pyruvate kinase M2 in colorectal cancer cells. Oncology Reports. 34: 1933-42. PMID 26252736 DOI: 10.3892/Or.2015.4178  0.512
2015 Netsirisawan P, Chokchaichamnankit D, Srisomsap C, Svasti J, Champattanachai V. Proteomic Analysis Reveals Aberrant O-GlcNAcylation of Extracellular Proteins from Breast Cancer Cell Secretion. Cancer Genomics & Proteomics. 12: 201-9. PMID 26136220  0.389
2014 Chaiyawat P, Netsirisawan P, Svasti J, Champattanachai V. Aberrant O-GlcNAcylated Proteins: New Perspectives in Breast and Colorectal Cancer. Frontiers in Endocrinology. 5: 193. PMID 25426101 DOI: 10.3389/Fendo.2014.00193  0.459
2013 Phueaouan T, Chaiyawat P, Netsirisawan P, Chokchaichamnankit D, Punyarit P, Srisomsap C, Svasti J, Champattanachai V. Aberrant O-GlcNAc-modified proteins expressed in primary colorectal cancer. Oncology Reports. 30: 2929-36. PMID 24126823 DOI: 10.3892/Or.2013.2794  0.501
2013 Champattanachai V, Netsirisawan P, Chaiyawat P, Phueaouan T, Charoenwattanasatien R, Chokchaichamnankit D, Punyarit P, Srisomsap C, Svasti J. Proteomic analysis and abrogated expression of O-GlcNAcylated proteins associated with primary breast cancer. Proteomics. 13: 2088-99. PMID 23576270 DOI: 10.1002/Pmic.201200126  0.521
2012 Charoenwattanasatien R, Cairns JR, Keeratichamroen S, Sawangareetrakul P, Tanpaiboon P, Wattanasirichaigoon D, Pangkanon S, Svasti J, Champattanachai V. Decreasing activity and altered protein processing of human iduronate-2-sulfatase mutations demonstrated by expression in COS7 cells. Biochemical Genetics. 50: 990-7. PMID 22990955 DOI: 10.1007/S10528-012-9538-9  0.309
2009 Zou L, Yang S, Champattanachai V, Hu S, Chaudry IH, Marchase RB, Chatham JC. Glucosamine improves cardiac function following trauma-hemorrhage by increased protein O-GlcNAcylation and attenuation of NF-{kappa}B signaling. American Journal of Physiology. Heart and Circulatory Physiology. 296: H515-23. PMID 19098112 DOI: 10.1152/Ajpheart.01025.2008  0.617
2008 Champattanachai V, Marchase RB, Chatham JC. Glucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein O-GlcNAc and increased mitochondrial Bcl-2. American Journal of Physiology. Cell Physiology. 294: C1509-20. PMID 18367586 DOI: 10.1152/Ajpcell.00456.2007  0.641
2007 Champattanachai V, Marchase RB, Chatham JC. Glucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein-associated O-GlcNAc. American Journal of Physiology. Cell Physiology. 292: C178-87. PMID 16899550 DOI: 10.1152/Ajpcell.00162.2006  0.65
2006 Nagy T, Champattanachai V, Marchase RB, Chatham JC. Glucosamine inhibits angiotensin II-induced cytoplasmic Ca2+ elevation in neonatal cardiomyocytes via protein-associated O-linked N-acetylglucosamine. American Journal of Physiology. Cell Physiology. 290: C57-65. PMID 16107505 DOI: 10.1152/Ajpcell.00263.2005  0.609
Show low-probability matches.